212 related articles for article (PubMed ID: 24358251)
1. Lysophosphatidylcholine and carotid intima-media thickness in young smokers: a role for oxidized LDL-induced expression of PBMC lipoprotein-associated phospholipase A2?
Fratta Pasini A; Stranieri C; Pasini A; Vallerio P; Mozzini C; Solani E; Cominacini M; Cominacini L; Garbin U
PLoS One; 2013; 8(12):e83092. PubMed ID: 24358251
[TBL] [Abstract][Full Text] [Related]
2. Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses.
Shi Y; Zhang P; Zhang L; Osman H; Mohler ER; Macphee C; Zalewski A; Postle A; Wilensky RL
Atherosclerosis; 2007 Mar; 191(1):54-62. PubMed ID: 16765356
[TBL] [Abstract][Full Text] [Related]
3. OxLDL stimulates lipoprotein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways.
Wang WY; Li J; Yang D; Xu W; Zha RP; Wang YP
Cardiovasc Res; 2010 Mar; 85(4):845-52. PubMed ID: 19910444
[TBL] [Abstract][Full Text] [Related]
4. Oxidized LDL induces procoagulant profiles by increasing lysophosphatidylcholine levels, lysophosphatidylethanolamine levels, and Lp-PLA
Kim M; Yoo HJ; Lee D; Lee JH
Nutr Metab Cardiovasc Dis; 2020 Jun; 30(7):1137-1146. PubMed ID: 32456947
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques.
Mannheim D; Herrmann J; Versari D; Gössl M; Meyer FB; McConnell JP; Lerman LO; Lerman A
Stroke; 2008 May; 39(5):1448-55. PubMed ID: 18356547
[TBL] [Abstract][Full Text] [Related]
6. Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation.
Gonçalves I; Edsfeldt A; Ko NY; Grufman H; Berg K; Björkbacka H; Nitulescu M; Persson A; Nilsson M; Prehn C; Adamski J; Nilsson J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1505-12. PubMed ID: 22499993
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein-associated phospholipase A
Öngen B; Kalkan Uçar S; Levent E; Azarsız E; Koloğlu T; Çoker M; Sözmen E; Sağın FG
Ann Clin Biochem; 2017 Sep; 54(5):539-547. PubMed ID: 27614353
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein-associated phospholipase A2 decreases oxidized lipoprotein cellular association by human macrophages and hepatocytes.
Yang M; Chu EM; Caslake MJ; Edelstein C; Scanu AM; Hill JS
Biochim Biophys Acta; 2010 Feb; 1801(2):176-82. PubMed ID: 19895904
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids.
Jackisch L; Kumsaiyai W; Moore JD; Al-Daghri N; Kyrou I; Barber TM; Randeva H; Kumar S; Tripathi G; McTernan PG
Diabetologia; 2018 May; 61(5):1155-1166. PubMed ID: 29427237
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children.
Ragab SM; Safan MA; Obeid OM; Sherief AS
Hematology; 2015 May; 20(4):228-38. PubMed ID: 25056687
[TBL] [Abstract][Full Text] [Related]
11. Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2.
Lourida ES; Georgiadis AN; Papavasiliou EC; Papathanasiou AI; Drosos AA; Tselepis AD
Arthritis Res Ther; 2007; 9(1):R19. PubMed ID: 17326817
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization.
Mahmut A; Boulanger MC; El Husseini D; Fournier D; Bouchareb R; Després JP; Pibarot P; Bossé Y; Mathieu P
J Am Coll Cardiol; 2014 Feb; 63(5):460-9. PubMed ID: 24161325
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein associated phospholipase A2 activity & its correlation with oxidized LDL & glycaemic status in early stages of type-2 diabetes mellitus.
Garg S; Madhu SV; Suneja S
Indian J Med Res; 2015 Jan; 141(1):107-14. PubMed ID: 25857502
[TBL] [Abstract][Full Text] [Related]
14. Replacing with whole grains and legumes reduces Lp-PLA2 activities in plasma and PBMCs in patients with prediabetes or T2D.
Kim M; Jeung SR; Jeong TS; Lee SH; Lee JH
J Lipid Res; 2014 Aug; 55(8):1762-71. PubMed ID: 24904022
[TBL] [Abstract][Full Text] [Related]
15. Circulating and PBMC Lp-PLA2 associate differently with oxidative stress and subclinical inflammation in nonobese women (menopausal status).
Paik JK; Kim JY; Kim OY; Lee Y; Jeong TS; Sweeney G; Jang Y; Lee JH
PLoS One; 2012; 7(2):e29675. PubMed ID: 22359537
[TBL] [Abstract][Full Text] [Related]
16. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease.
Ikonomidis I; Kadoglou NN; Tritakis V; Paraskevaidis I; Dimas K; Trivilou P; Papadakis I; Tzortzis S; Triantafyllidi H; Parissis J; Anastasiou-Nana M; Lekakis J
Atherosclerosis; 2014 May; 234(1):34-41. PubMed ID: 24594367
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.
Ross Eckard A; Longenecker CT; Jiang Y; Debanne SM; Labbato D; Storer N; McComsey GA
HIV Med; 2014 Oct; 15(9):537-46. PubMed ID: 24650269
[TBL] [Abstract][Full Text] [Related]
18. Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome.
Rosenson RS
Am Heart J; 2008 Mar; 155(3):499.e9-16. PubMed ID: 18294485
[TBL] [Abstract][Full Text] [Related]
19. Prehypertension-associated elevation in circulating lysophosphatidlycholines, Lp-PLA2 activity, and oxidative stress.
Kim M; Jung S; Kim SY; Lee SH; Lee JH
PLoS One; 2014; 9(5):e96735. PubMed ID: 24800806
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients.
Mangili A; Ahmad R; Wolfert RL; Kuvin J; Polak JF; Karas RH; Wanke CA
Clin Infect Dis; 2014 Mar; 58(6):893-900. PubMed ID: 24336757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
